NDC 70069-441-01 - DICYCLOMINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70069-441
- Requested NDC
- 70069-441-01
- Package NDCs from labels
- 70069-441-01, 70069-441-05
- Manufacturer
- Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited
- Effective date
- 2024-11-05
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| DICYCLOMINE - Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | Somerset Therapeutics, LLC | Somerset Therapeutics Private Limited | 2024-11-05 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70069-441-01 | DICYCLOMINE HYDROCHLORIDE | 2 mL in 1 AMPULE | INJECTION, SOLUTION | 2 | 5 | |
| 70069-441-05 | DICYCLOMINE HYDROCHLORIDE | 5 in 1 CARTON | INJECTION, SOLUTION | 5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70069-441-01 | ML - Milliliter | 70069-441 | 6608465f-7c64-4411-9cef-7d5a475da1c3 | 1 | 2024-12-10 |
| 70069-441-05 | ML - Milliliter | 70069-441 | 78e034c3-d360-434c-9d44-e5a333e9a04f | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Chloride | SODIUM CHLORIDE | YYBA CORP | 597f3347-647c-3545-e063-6294a90abab2 | 2026-08-20 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 2e5fe9f4-78e5-4af4-8bf9-9680e5dc5e88 | 2026-08-20 | Warnings, Adverse reactions | 451W47IQ8X |
| Sinusforce-HP | ARSENICUM ALBUM, HEPAR SULPHURIS CALCAREUM, KALI BICHROMICUM, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), SEPIA | BioActive Nutritional, Inc. | 53c96680-210b-4426-8b41-3b9a882848dd | 2026-08-20 | Warnings | 451W47IQ8X |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Major Pharmaceuticals | 5eee0dff-d157-4534-adfb-c035b7042c07 | 2026-08-20 | Warnings, Adverse reactions | CQ903KQA31 |
| CVS Saline | NASAL | CVS PHARMACY | f02c41b0-c78e-41cd-aa4a-2756bbe92087 | 2026-08-19 | Warnings | 451W47IQ8X |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | df18a603-ca12-4b26-83b5-9dd07b6453ab | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Redpharm Drug | 594b6832-a31c-4de2-e063-6294a90a05fa | 2026-08-18 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | REMEDYREPACK INC. | 2c36b79f-153c-446c-899b-6e28ccff1dc8 | 2026-08-18 | Warnings, Adverse reactions | CQ903KQA31 |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | bbc5b820-4973-11e2-a192-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | c29bdfa0-4976-11e2-939b-0002a5d5c51b | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| DELFLEX | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | 515dcee0-3e34-11e2-a25f-0800200c9a66 | 2026-08-18 | Warnings, Adverse reactions | 451W47IQ8X |
| BM BM63 DROPS | CEANOTHUS, KALI ARSEN, KALI MUR, SELENIUM, THALLIUM, WIESBADEN | BM Private Limited | 59006d82-610a-2e08-e063-6394a90af1ed | 2026-08-14 | Warnings | 059QF0KO0R |
| BM BM173 DROPS | ECHINACEA, EUPHRASIA, NATRUM MUR, RHUS TOX, SILICEA, SULPHUR, URTICA UREN | BM Private Limited | 59036ca4-e7bb-bbe7-e063-6394a90a410a | 2026-08-14 | Warnings | 451W47IQ8X |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Redpharm Drug | 58e713f9-6412-0a1a-e063-6394a90a91b6 | 2026-08-13 | Warnings, Adverse reactions | CQ903KQA31 |
| Natural Lift Lack of energy - Fatigue | AVENA SATIVA 9C, GELSEMIUM SEMPERVIRENS 9C, PANAX GINSENG 3C, NATRUM MURIATICUM 9C | SEVENE USA | 551194c4-dfd8-c42d-e063-6294a90aecee | 2026-08-13 | Warnings | 451W47IQ8X |
| BM BM59 DROPS | CALC CARB, DULCAMARA, HEPAR SULPH, LYCOPODIUM, NAT MUR, SULPHUR, THUJA OCC | BM Private Limited | 58ef0755-c2cd-b7c2-e063-6294a90a2707 | 2026-08-13 | Warnings | 451W47IQ8X |
| Dicyclomine Hydrochloride | DICYCLOMINE HYDROCHLORIDE | Cardinal Health 107, LLC | 793a3f0c-ea45-4e28-a98a-610cf9eddad8 | 2026-08-12 | Warnings, Adverse reactions | CQ903KQA31 |
| DICYCLOMINE HYDROCHLORIDE | DICYCLOMINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | 9d249073-0171-4bb0-8cad-13cb3713159f | 2026-08-12 | Warnings, Adverse reactions | CQ903KQA31 |
| Dicyclomine hydrochloride | DICYCLOMINE HYDROCHLORIDE | Preferred Pharmaceuticals Inc. | de44e605-14a3-4b40-bf1b-2ac857eb7b12 | 2026-08-12 | Warnings, Adverse reactions | CQ903KQA31 |
| Adrenal-Tone | ADRENALINUM, AVENA, GINKGO, GLYCYRRHIZA, KALI PHOS, NAT MUR, NUX VOMICA, PHOSPHORICUM AC, PITUITARUM POSTERIUM, SARSAPARILLA, THYROIDINUM, VERATRUM ALB, ZINC MET. | Energetix Corporation | 1ea4abb3-3a02-4d5c-baeb-d903b0febbb5 | 2026-08-11 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.